Literature DB >> 17224249

Urinary excretion of acrylamide and metabolites in Fischer 344 rats and B6C3F(1) mice administered a single dose of acrylamide.

Daniel R Doerge1, Nathan C Twaddle, Melanie I Boettcher, L Patrice McDaniel, Jürgen Angerer.   

Abstract

Acrylamide (AA) is a widely studied industrial chemical that is neurotoxic, mutagenic to somatic and germ cells, and carcinogenic in mice and rats. AA is also formed during cooking in many commonly consumed starchy foods. Our previous toxicokinetic investigations of AA and its genotoxic metabolite, glycidamide (GA), in rodents showed that AA is highly bioavailable from oral routes of administration, is widely distributed to tissues, and that the dietary route, in particular, favors metabolism to GA. Formation and accumulation of mutagenic GA-DNA adducts in many tissues support the hypothesis that AA is carcinogenic in rodent bioassays through metabolism to GA. The current investigation describes the quantification of 24 h urinary metabolites, including free AA and GA and their mercapturic acid conjugates (AAMA and GAMA, respectively), using LC/MS/MS in F344 rats and B6C3F(1) mice following a dose of 0.1 mg/kg bw given by intravenous, gavage, and dietary routes of administration. Similar groups of rodents were used previously for serum/tissue toxicokinetic and adduct determinations (DNA and hemoglobin). The goal was to investigate relationships between urinary and circulating biomarkers of exposure, toxicokinetic parameters for AA and GA, and tissue GA-DNA adducts in rodents from single doses of AA. Significant linear correlations were observed between urinary levels of AA with AAMA and GA with GAMA in the current data sets for rats and mice. Concentrations of AA and AAMA correlated significantly with average AUC values determined previously for AA in groups of rats and mice similarly dosed with AA. Urinary GA and GAMA concentrations showed significant correlations with average AUC values for GA and liver GA-DNA adducts determined previously in rats and mice similarly dosed with AA. Despite statistical significance, considerable inter-animal variability was observed in all urinary measurements, which limited the degree of correlation with either average toxicokinetic or biomarker data collected from different groups of animals. These results suggest that urinary measurements of AA and its metabolites may be useful for prediction of internal exposures to AA and GA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17224249     DOI: 10.1016/j.toxlet.2006.12.002

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Biological monitoring for occupational acrylamide exposure from acrylamide production workers.

Authors:  Yu-Fang Huang; Kuen-Yuh Wu; Saou-Hsing Liou; Shi-Nian Uang; Chu-Chih Chen; Wei-Chung Shih; Shih-Chuan Lee; Chih-Chun Jean Huang; Mei-Lien Chen
Journal:  Int Arch Occup Environ Health       Date:  2010-07-02       Impact factor: 3.015

Review 2.  Human exposure to selected animal neurocarcinogens: a biomarker-based assessment and implications for brain tumor epidemiology.

Authors:  Dora Il'yasova; Bridget J McCarthy; Serap Erdal; Joanna Shimek; Jennifer Goldstein; Daniel R Doerge; Steven R Myers; Paolo Vineis; John S Wishnok; James A Swenberg; Darell D Bigner; Faith G Davis
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2009-03       Impact factor: 6.393

3.  Acrylamide Production in Autoclaved Rodent Feed.

Authors:  David M Kurtz; Rallene Glascoe; Gordon Caviness; Jacqueline Locklear; Tanya Whiteside; Toni Ward; Floyd Adsit; Fred Lih; Leesa J Deterding; Mona I Churchwell; Daniel R Doerge; Grace E Kissling
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-10-25       Impact factor: 1.232

4.  Beyond detoxification: Pleiotropic functions of multiple glutathione S-transferase isoforms protect mice against a toxic electrophile.

Authors:  Kelsey A Behrens; Leigh A Jania; John N Snouwaert; MyTrang Nguyen; Sheryl S Moy; Andrey P Tikunov; Jeffrey M Macdonald; Beverly H Koller
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.